Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004–2007 and 2008–2011

Archives of Virology

Volumn 159, Issue 12, 2014, Pages 3231-3237

  Rong, Xia ^a   Xu, Ru ^a   Xiong, Huaping ^a   Wang, Min ^a   Huang, Ke ^a   Chen, Qiuyu ^a   Li, Chengyao ^b   Liao, Qiao ^a   Huang, Jieting ^a   Xia, Wenjie ^a   Luo, Guangping ^a   Ye, Xin ^a   Zhang, Ming ^c   Fu, Yongshui ^a  

^a Guangzhou Blood Center   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

CHINA; CLASSIFICATION; DEMOGRAPHY; DNA SEQUENCE; EPIDEMIOLOGY; GENETICS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMAN; ISOLATION AND PURIFICATION; PHYLOGEOGRAPHY; PREVALENCE; VIROLOGY;

CHINA; DEMOGRAPHY; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; PHYLOGEOGRAPHY; PREVALENCE; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84922393292     PISSN: 03048608     EISSN: 14328798     Source Type: Journal    
DOI: 10.1007/s00705-014-2185-1     Document Type: Article

References (46)

1. Global Burden of Hepatitis C Working Group (2004) Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 44(1):20–29
2. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P (2014) Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatology 59:318–327
3. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962–973
4. Mahaney K, Tedeschi V, Maertens G, Di Bisceglie AM, Vergalla J, Hoofnagle JH, Sallie R (1994) Genotypic analysis of hepatitis C virus in American patients. Hepatology 20:1405–1411
5. Grassi E, Aghemo A (2013) How to optimize HCV therapy in genotype 2 patients. Liver Int 33(Suppl 1):35–40
6. Lagging M, Rembeck K, Rauning Buhl M, Christensen P, Dalgard O, Farkkila M, Hellstrand K, Langeland N, Lindh M, Westin J, Norkrans G (2013) Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse. Scand J Gastroenterol 48:839–847
7. Abe H, Aida Y, Ishiguro H, Yoshizawa K, Seki N, Miyazaki T, Itagaki M, Sutoh S, Ika M, Kato K, Shimada N, Tsubota A, Aizawa Y (2013) New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection. J Med Virol 85:1523–1533
8. Inamullah IM, Ahmed H, Sajidulg AM, Ali L, Ahmed A (2011) Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. Virol J 8:16
9. Chakravarti A, Ashraf A, Malik S (2013) A study of changing trends of prevalence and genotypic distribution of hepatitis C virus among high risk groups in North India. Indian J Med Microbiol 31:354–359
10. Verbeeck J, Maes P, Lemey P, Pybus OG, Wollants E, Song E, Nevens F, Fevery J, Delport W, Van der Merwe S, Van Ranst M (2006) Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol 80:4220–4226
11. Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Tanaka Y, Mizokami M, Poovorawan Y (2010) Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand. J Med Virol 82:257–262
12. Nguyen NH, Vutien P, Trinh HN, Garcia RT, Nguyen LH, Nguyen HA, Nguyen KK, Nguyen MH (2010) Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans. Hepatol Int 4:523–529
13. Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH (2005) Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 75:538–549
14. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958–965
15. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975–982
16. Casey LC, Lee WM (2013) Hepatitis C virus therapy update. Curr Opin Gastroenterol 29:243–249
17. Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L (2008) Changing HCV genotypes distribution in Poland–relation to source and time of infection. J Clin Virol 42:156–159
18. Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M (2000) Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol 60:122–125
19. Maieron A, Metz-Gercek S, Hackl F, Luger C, Ziachehabi A, Strauss R, Schofl R, Mittermayer H (2010) Chronic hepatitis C in Austria, 1992-2006: genotype distribution and demographic factors. Euro Surveill 15:19492
20. Bourliere M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustiere C, Perrier H, Jullien M, Lambot G, Loyer R, LeBars O, Daniel R, Khiri H, Halfon P (2002) Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat 9:62–70
21. Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M (2011) Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol 21:401–416
22. Lavanchy D (2009) The global burden of hepatitis C. Liver Int 29(Suppl 1):74–81
23. Ding X, Gu H, Zhong ZH, Zilong X, Tran HT, Iwaki Y, Li TC, Sata T, Abe K (2003) Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China. Jpn J Infect Dis 56:19–22
24. Nakano T, Lu L, He Y, Fu Y, Robertson BH, Pybus OG (2006) Population genetic history of hepatitis C virus 1b infection in China. J Gen Virol 87:73–82
25. Wu RR, Mizokami M, Lau JY, Ohno T, Fang ZX, Ohba K, Wu XS, Hata A, Sasaki M, Iino S (1995) Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, western China. J Med Virol 45:174–178
26. Holland PV, Barrera JM, Ercilla MG, Yoshida CF, Wang Y, de Olim GA, Betlach B, Kuramoto K, Okamoto H (1996) Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method. J Clin Microbiol 34:2372–2378
27. Hwang SJ, Lee SD, Chan CY, Lu RH, Lo KJ (1994) A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 21:831–836
28. Fu Y, Wang Y, Xia W, Pybus OG, Qin W, Lu L, Nelson K (2011) New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat 18:42–52
29. Fu Y, Xia W, Wang Y, Tian L, Pybus OG, Lu L, Nelson K (2010) The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models. Transfusion 50:1505–1511
30. Fu Y, Qin W, Cao H, Xu R, Tan Y, Lu T, Wang H, Tong W, Rong X, Li G, Yuan M, Li C, Abe K, Lu L, Chen G (2012) HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS One 7:e28006
31. Rong X, Lu L, Wang J, Xiong H, Huang J, Chen J, Huang K, Xu R, Wang M, Zhang X, Guo T, Liu Y, Gao G, Fu Y, Nelson KE (2012) Correlation of viral loads with HCV genotypes: higher levels of virus were revealed among blood donors infected with 6a strains. PLoS One 7:e52467
32. Dong ZX, Zhou HJ, Wang JH, Xiang XG, Zhuang Y, Guo SM, Gui HL, Zhao GD, Tang WL, Wang H, Xie Q (2012) Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients’ characteristics and clinical parameters. J Dig Dis 13:564–570
33. Seto WK, Lai CL, Fung J, Hung I, Yuen J, Young J, Wong DK, Yuen MF (2010) Natural history of chronic hepatitis C: genotype 1 versus genotype 6. J Hepatol 53:444–448
34. Li CS, Chan PK, Tang JW (2009) Molecular epidemiology of hepatitis C genotype 6a from patients with chronic hepatitis C from Hong Kong. J Med Virol 81:628–633
35. Beach MV (2001) “Blood heads” and AIDS haunt China’s countryside. Lancet 357:49
36. Yan Z, Fan K, Wang Y, Fan Y, Tan Z, Deng G (2012) Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china. Hepat Mon 12:196–204
37. Yue QH, Zhang XQ, Shang Y, Chen YZ, Sun WL, Su MQ, Mu SJ, Hao XK, Hu XB (2010) Anti-HCV reactive volunteer blood donors distribution character and genotypes switch in Xi’an, China. Virol J 7:186
38. Sulkowski MS, Ray SC, Thomas DL (2002) Needlestick transmission of hepatitis C. Jama 287:2406–2413
39. Fung J, Lai CL, Hung I, Young J, Cheng C, Wong D, Yuen MF (2008) Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin. J Infect Dis 198:808–812
40. Hui CK, Yuen MF, Sablon E, Chan AO, Wong BC, Lai CL (2003) Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1. J Infect Dis 187:1071–1074
41. Nguyen NH, VuTien P, Garcia RT, Trinh H, Nguyen H, Nguyen K, Levitt B, Nguyen MH (2010) Response to pegylated interferon and ribavirin in Asian American patients with chronic hepatitis C genotypes 1 vs 2/3 vs 6. J Viral Hepat 17:691–697
42. Lam KD, Trinh HN, Do ST, Nguyen TT, Garcia RT, Nguyen T, Phan QQ, Nguyen HA, Nguyen KK, Nguyen LH, Nguyen MH (2010) Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6. Hepatology 52:1573–1580
43. Patel K, Muir AJ, McHutchison JG (2006) Diagnosis and treatment of chronic hepatitis C infection. Bmj 332:1013–1017
44. Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, Yu XF (2004) Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 33:182–188
45. van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, Vogel M, Baumgarten A, Chaix ML, Fisher M, Gotz H, Matthews GV, Neifer S, White P, Rawlinson W, Pol S, Rockstroh J, Coutinho R, Dore GJ, Dusheiko GM, Danta M (2009) Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 136:1609–1617
46. Murakami J, Nagata I, Iitsuka T, Okamoto M, Kaji S, Hoshika T, Matsuda R, Kanzaki S, Shiraki K, Suyama A, Hino S (2012) Risk factors for mother-to-child transmission of hepatitis C virus: maternal high viral load and fetal exposure in the birth canal. Hepatol Res 42:648–657